Testosterone for a trading edge
A doctor who specializes in testosterone therapy says most of his patients are affiliated with the financial industry.
More and more Wall Street types are undergoing testosterone treatments “in the hope of being turned into alpha males,” said Charles Wallace in the Financial Times. Exhausted from “working Stakhanovite hours” and fearful of losing their jobs, many bankers and traders hope male-hormone supplements will “sharpen their faculties and make them more competitive.” Dr. Lionel Bissoon, who once treated women for cellulite on Manhattan’s Upper West Side, now specializes in testosterone therapy. “Ninety percent of my patients have some involvement in the finance industry,” he says. While some blame testosterone for the “machismo and aggressive risk-taking” that caused the financial crisis, Bissoon’s patients swear by the stuff. It promotes “the positive side of aggression,“ says John, 40, a venture capital executive.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Brazil has a scorpion problem
Under The Radar Venomous arachnids are infesting country's fast-growing cities
-
Why Rikers Island will no longer be under New York City's control
The Explainer A 'remediation manager' has been appointed to run the infamous jail
-
California may pull health care from eligible undocumented migrants
IN THE SPOTLIGHT After pushing for universal health care for all Californians regardless of immigration status, Gov. Gavin Newsom's latest budget proposal backs away from a key campaign promise
-
The news at a glance...International
feature International
-
The bottom line
feature Youthful startup founders; High salaries for anesthesiologists; The myth of too much homework; More mothers stay a home; Audiences are down, but box office revenue rises
-
The week at a glance...Americas
feature Americas
-
The news at a glance
feature Comcast defends planned TWC merger; Toyota recalls 6.39 million vehicles; Takeda faces $6 billion in damages; American updates loyalty program; Regulators hike leverage ratio
-
The news at a glance...United States
feature United States
-
The bottom line
feature The rising cost of graduate degrees; NSA surveillance affects tech profits; A glass ceiling for female chefs?; Bonding to a brand name; Generous Wall Street bonuses
-
The news at a glance
feature GM chief faces Congress; FBI targets high-frequency trading; Yellen confirms continued low rates; BofA settles mortgage claims for $9.3B; Apple and Samsung duke it out
-
The week at a glance...International
feature International